The Genomics of Auditory Function and Disease
- PMID: 35667089
- PMCID: PMC10644960
- DOI: 10.1146/annurev-genom-121321-094136
The Genomics of Auditory Function and Disease
Abstract
Current estimates suggest that nearly half a billion people worldwide are affected by hearing loss. Because of the major psychological, social, economic, and health ramifications, considerable efforts have been invested in identifying the genes and molecular pathways involved in hearing loss, whether genetic or environmental, to promote prevention, improve rehabilitation, and develop therapeutics. Genomic sequencing technologies have led to the discovery of genes associated with hearing loss. Studies of the transcriptome and epigenome of the inner ear have characterized key regulators and pathways involved in the development of the inner ear and have paved the way for their use in regenerative medicine. In parallel, the immense preclinical success of using viral vectors for gene delivery in animal models of hearing loss has motivated the industry to work on translating such approaches into the clinic. Here, we review the recent advances in the genomics of auditory function and dysfunction, from patient diagnostics to epigenetics and gene therapy.
Keywords: deafness; epigenetics; gene therapy; genomics; hearing loss; regeneration.
Figures





Similar articles
-
Adeno-associated virus gene replacement for recessive inner ear dysfunction: Progress and challenges.Hear Res. 2020 Sep 1;394:107947. doi: 10.1016/j.heares.2020.107947. Epub 2020 Mar 18. Hear Res. 2020. PMID: 32247629 Free PMC article. Review.
-
[Gene therapy for human hearing loss: challenges and promises].Med Sci (Paris). 2013 Oct;29(10):883-9. doi: 10.1051/medsci/20132910016. Epub 2013 Oct 18. Med Sci (Paris). 2013. PMID: 24148127 Review. French.
-
Emerging Gene Therapies for Genetic Hearing Loss.J Assoc Res Otolaryngol. 2017 Oct;18(5):649-670. doi: 10.1007/s10162-017-0634-8. Epub 2017 Aug 16. J Assoc Res Otolaryngol. 2017. PMID: 28815315 Free PMC article. Review.
-
Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.Hear Res. 2020 Sep 1;394:107931. doi: 10.1016/j.heares.2020.107931. Epub 2020 Mar 5. Hear Res. 2020. PMID: 32173115 Free PMC article. Review.
-
Identification of Adeno-Associated Viral Vectors That Target Neonatal and Adult Mammalian Inner Ear Cell Subtypes.Hum Gene Ther. 2016 Sep;27(9):687-99. doi: 10.1089/hum.2016.053. Epub 2016 Jun 24. Hum Gene Ther. 2016. PMID: 27342665 Free PMC article.
Cited by
-
A murine model for the del(GJB6-D13S1830) deletion recapitulating the phenotype of human DFNB1 hearing impairment: generation and functional and histopathological study.BMC Genomics. 2024 Apr 11;25(1):359. doi: 10.1186/s12864-024-10289-z. BMC Genomics. 2024. PMID: 38605287 Free PMC article.
-
Hair cell toxicology: With the help of a little fish.Front Cell Dev Biol. 2022 Dec 13;10:1085225. doi: 10.3389/fcell.2022.1085225. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36582469 Free PMC article. Review.
-
Liquid-liquid phase separation in hair cell stereocilia development and maintenance.Comput Struct Biotechnol J. 2023 Feb 24;21:1738-1745. doi: 10.1016/j.csbj.2023.02.040. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 36890881 Free PMC article. Review.
-
Clarin-2 gene supplementation durably preserves hearing in a model of progressive hearing loss.Mol Ther. 2024 Mar 6;32(3):800-817. doi: 10.1016/j.ymthe.2024.01.021. Epub 2024 Jan 18. Mol Ther. 2024. PMID: 38243601 Free PMC article.
-
Transcriptomic Analysis Identifies Candidate Genes for Differential Expression during Xenopus laevis Inner Ear Development.bioRxiv [Preprint]. 2024 Jan 1:2023.12.29.573599. doi: 10.1101/2023.12.29.573599. bioRxiv. 2024. PMID: 38260420 Free PMC article. Preprint.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical